The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cytokeratin 19 expression as a risk factor for metastasis in cutaneous squamous cell carcinoma.
 
Hisashi Uhara
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Maruho; MSD; Novartis; Ono Pharmaceutical; ProPharma
Consulting or Advisory Role - Bristol-Myers Squibb; Chugai Pharma; Kyowa Hakko Kirin; MSD; Novartis; Ono Pharmaceutical
Speakers' Bureau - Bristol-Myers Squibb; Chugai Pharma; Janssen; Kyowa Hakko Kirin; Mitsubishi Tanabe Pharma; MSD; Novartis; Ono Pharmaceutical; ProPharma
Research Funding - Abbvie (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Kaken Pharmaceutical (Inst); Kyowa Hakko Kirin (Inst); Maruho (Inst); Mitsubishi Tanabe Pharma (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); Nihonkayaku (Inst); Ono Pharmaceutical (Inst); ProPharma (Inst); Taiho Pharmaceutical (Inst); Torii Pharmaceutical (Inst); Tsumura & Co. (Inst)
 
Junji Kato
Research Funding - Abbvie (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Kaken Pharmaceutical (Inst); Kyowa Hakko Kirin (Inst); Maruho (Inst); Mitsubishi Tanabe Pharma (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); Nihonkayaku (Inst); Ono Pharmaceutical (Inst); ProPharma (Inst); Taiho Pharmaceutical (Inst); Torii Pharmaceutical (Inst); Tsumura & Co. (Inst)
 
Tokimasa Hida
Honoraria - Kaken Pharmaceutical
Research Funding - Abbvie (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Kaken Pharmaceutical (Inst); Kyowa Hakko Kirin (Inst); Maruho (Inst); Mitsubishi Tanabe Pharma (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); Nihonkayaku (Inst); Ono Pharmaceutical (Inst); ProPharma (Inst); Taiho Pharmaceutical (Inst); Torii Pharmaceutical (Inst); Tsumura & Co. (Inst)